|
|
|||||||
|
UCSF NEWS Cayuse has released Cayuse424 version 3.1. This release incorporates a wide variety of feedback from customers currently using 3.0. Cayuse ensures that the upgrade process will be smooth and transparent and will further enhance the value we get from Cayuse424. [more ...] Fringe Benefit Rates on Proposals-Update The campus fringe benefit rate guidance memo was amended in March 2006 to include projected increases in fringe benefit rates due to anticipated UC Employer/Employee contributions to the UC Retirement System. [more...] Four faculty members were selected through the Office of Sponsored Research Limited Submission process as final nominees for the California Institute for Regenerative Medicine’s New Faculty Award. They are, in the New Faculty Award category, Emmanuelle Passegue, PhD and Jeremy Reiter, MD, PhD. The two candidates who were selected in the New Faculty Physician Scientist Award are Robert Blelloch, MD, PhD and Ophir Klein, < MD , PhD. [more...] National News FDA Issues Two Guidance Documents — One Final, One Draft The Federal Register contains two new guidance documents from the Food and Drug Administration (FDA). [more...] NIH Establishes Working Groups to Examine Peer Review The National Institutes of Health (NIH) formed two working groups — one external, the other internal — to examine the NIH process for peer review of grant applications. [more...] FBI Is Talking to Researchers About Preventing Terrorist Use of Research Information An agent from the Boston division of the Federal Bureau of Investigation (FBI) recently met with researchers at several area universities "alerting them to potential security risks that could lead to mass destruction. " [more...] HHS OIG to Investigate NIH and Grantees' Conflict of Interest Policies The Office of Inspector General (OIG) in the Department of Health and Human
Services (HHS) has recently begun a review of how NIH "oversees conflict
of interest on the part of its grantees." [more...] FDA Proposes Financial Conflict of Interest Requirements for Advisory Committee Members The Food and Drug Administration (FDA) announced new proposed "guidance" that would implement stricter financial conflict of interest requirements for members of its advisory committees and for eligibility for meeting participation. [more...]
|
||||||